In This Section

Program

Please Note: All session times for the AACR Virtual Special Conference: Brain Cancer are U.S. Eastern Time (ET).

Monday, October 25, 2021

Opening Keynote Talk: Chromatin Architecture in Cancer
Plenary Session 1: Epigenetics and Epitranscriptomics/Panel Session
Plenary Session 2: Novel Therapeutics/Panel Session

tuesday, october 26, 2021

Plenary Session 3: Metabolism and the Tumor Microenvironment
Forum: Controversies in Clinical Care
Forum: Drug Design for Better CNS Penetration
Closing Keynote Lecture: Diversity in Neuro-oncology

Monday, October 25, 2021

OPENING KEYNOTE LectureS
10-11:15 a.m.

Title to be announced
Job Dekker, University of Massachusetts Medical School, Worcester, Massachusetts

Single cell epigenomics
Bing Ren, University of Southern California San Diego, San Diego, California

Break
11:15-11:30 a.m.
Plenary Session 1: Epigenetics and Epitranscriptomics
11:30-12:30 p.m.

RNA methylation in human cancer
Chaun He, The University of Chicago/ Howard Hughes Medical Institute, Chicago, Illinois

Deconvolution of chromatin programs of stemness at single cell resolution            
Marco Gallo, University of Calgary Cumming School of Medicine, Calgary, Canada

Title to be announced
Itay Tirosh, Weizmann Institute of Science, Rehovot, Israel

Panel Discussion
12:30-1 p.m
Break
1-1:15 p.m.
Plenary Session 2: Novel Therapeutics
1:15-2:15 p.m.

Immunocytokines to treat glioblastoma
Michael Weller, University Hospital Zurich, Switzerland

Integrated development of a brain-penetrant EGFR inhibitor and non-invasive predictive biomarker of response for glioblastoma
David A. Nathanson, University of California Los Angeles, Los Angeles, California

Advancing CAR T cell therapy for glioblastoma
Christine E. Brown, City of Hope National Medical Center, Duarte, California

Panel discussion
2:15-2:45 p.m.

TUESDAY, OCTOBER 26, 2021

Plenary Session 3: Metabolism and the Tumor Microenvironment
10-11 a.m.

Title to be announced
Celeste Simon, Abramson Family Cancer Research Institute, Philadelphia, Pennsylvania

Title to be announced
Lewis C. Cantley, Weill Cornell Medicine, New York, New York

Additional speaker to be announced

panel discussion
11-11:30 a.m.
break
11:30-11:45 a.m.
Forum: Controversies in Clinical Care
11:45 a.m.-12:30 p.m.

Roger Stupp, Northwestern University Feinberg School of Medicine, Chicago, Illinois

Additional speaker to be announced

Break
12:30-12:45 p.m.
Forum: Drug Design for Better CNS Penetration
12:45-1:30 p.m.

Aberrant DNA repair as a therapeutic target in glioblastoma
Petra Hamerlik, Danish Cancer Society Research Center, Copenhagen, Denmark

Additional speakers to be announced

break
1:30-1:45 p.m.
CLOSING KEYNOTE
1:45-2:30 p.m.

Precision immunotherapy targeting malignant brain tumors
Duane A. Mitchell, University of Florida, Gainesville, Florida

closing remarks
2:30-2:45 p.m.